Facebook
Twitter
LinkedIn
ForwardBecome an ID/HIV Advocate Learning Series
Note: You must be an Active IDSA member to enroll in this course. To lean more about membership, please visit idsociety.org.
The ID/HIV Advocacy Learning Series is a five-module course developed by IDSA and HIVMA to empower infectious diseases and HIV professionals with the knowledge and skills to become effective advocates. Through this series, learners will explore the foundations of advocacy, understand key issues such as antimicrobial resistance and federal funding for ID/HIV programs, learn strategies to strengthen the ID/HIV workforce, and gain practical guidance on engaging with lawmakers.
Target Audience
Infectious diseases (ID) physicians and fellows
HIV care providers
Advanced practice providers (APPs) in ID and HIV (e.g., nurse practitioners, physician assistants)
Pharmacists involved in ID/HIV care or stewardship
Public health professionals working in infectious diseases
Medical and public health students with an interest in advocacy
ID/HIV program administrators and policy staff
Members of IDSA and HIVMA seeking to engage in advocacy efforts
Clinicians and researchers interested in influencing healthcare policy
Learning Objectives
By the end of this course, learners will be able to:
Define the role and importance of advocacy in advancing ID and HIV-related healthcare policies.
Describe the impact of antimicrobial resistance and outline advocacy strategies to address it.
Identify key sources of federal funding for ID/HIV programs and explain how advocacy influences budget decisions.
Discuss current challenges facing the ID/HIV workforce and articulate policy solutions to support recruitment and retention.
Demonstrate how to effectively participate in meetings with lawmakers and communicate policy priorities.
Recognize how IDSA and HIVMA support advocacy efforts and how members can get involved.
Faculty | Role | COI Disclosures |
Alice Kim; MD, MPH | Planner | Nothing to disclose |
Andrew Trotter; MD, MPH | Planner | Gilead Sciences, American Board of Internal Medicine Foundation |
Barbara Gripshover; MD | Planner | NIH |
Birgitt Dau; MD, MPH | Planner | Nothing to Disclose |
Carmen Rexach; MD | Planner | Nothing to Disclose |
Elizabeth Sherman; MD | Planner | Nothing to Disclose |
Geneen Gibson; MD | Planner | Nothing to Disclose |
Haley Pritchard; MD, MS | Planner | Nothing to Disclose |
Judith Feinberg; MD, MS | Planner | NIDA, NIGMS |
Kinna Thakarar; MD | Planner | SAMHSA, NHLBI, HRSA, NIH |
Maricar Malinis, PHD | Planner | Aicuris, NIH (Sub-grant) |
Misha Huang; PharnD | Planner | Nothing to Disclose |
Rachel Bender Ignacio; DMD, MD | Planner | NIH, ViiV |
Rabita Aziz; MPH | Staff | Nothing to Disclose |
All relevant financial relationships have been mitigated.
Accreditation Statement
In support of improving patient care, IDSA is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statement
IDSA designates this enduring material for a maximum of 2 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Recognition Statement
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Physician participation information will be shared with ABIM through ACCME PARS.
Available Credit
- 2.00 ABIM MOC II
- 2.00 ACPE Pharmacy
- 2.00 AMA PRA Category 1 Credit(s)™